Cargando…

An Available Strategy for Nasal Brain Transport of Nanocomposite Based on PAMAM Dendrimers via In Situ Gel

Polyamidoamine (PAMAM) dendrimers are efficient drug carriers. The presence of a physiological pathway for nasal brain transport provides a potential path for direct brain-targeted delivery of dendrimer nanocomposites. In this study, we synthesized PAMAM dendrimer composites with a nanoscale size; t...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Huichao, Li, Lingjun, Sun, Yue, Wang, Yuzhen, Gao, Shuang, Tian, Yuan, Ma, Xuemei, Guo, Chengcheng, Bo, Fumin, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409925/
https://www.ncbi.nlm.nih.gov/pubmed/30682799
http://dx.doi.org/10.3390/nano9020147
_version_ 1783402106208649216
author Xie, Huichao
Li, Lingjun
Sun, Yue
Wang, Yuzhen
Gao, Shuang
Tian, Yuan
Ma, Xuemei
Guo, Chengcheng
Bo, Fumin
Zhang, Li
author_facet Xie, Huichao
Li, Lingjun
Sun, Yue
Wang, Yuzhen
Gao, Shuang
Tian, Yuan
Ma, Xuemei
Guo, Chengcheng
Bo, Fumin
Zhang, Li
author_sort Xie, Huichao
collection PubMed
description Polyamidoamine (PAMAM) dendrimers are efficient drug carriers. The presence of a physiological pathway for nasal brain transport provides a potential path for direct brain-targeted delivery of dendrimer nanocomposites. In this study, we synthesized PAMAM dendrimer composites with a nanoscale size; the particle size of PAE (Paeonol)/mPEG (the heterofunctional PEG polymer with a methoxy)-PAMAM G5.NHAc and mPEG-PAMAM G5.NH(2)-FITC were 72.41 ± 11.58 nm and 96.51 ± 7.77 nm, and the zeta potential of PAE/mPEG-PAMAM G5.NHAc and mPEG-PAMAM G5.NH(2)-FITC were + 0.57 ± 0.11 mv and + 9.60 ± 0.41 mv, respectively. The EE% and DL% of PAE in PAE/mPEG-PAMAM G5.NHAc were 53.77% and 13.92%, respectively. PAE/mPEG-PAMAM G5.NHAc/DGG ionic-sensitive in situ gel was prepared, the viscosity of solution and gel state were 112 ± 3.2 mPa and 1403 ± 38.5 mPa, respectively. The in vitro goat mucoadhesive strength of the gel was 4763.36 ± 85.39 dyne/cm(2). In situ gel system was proven to be a non-Newtonian pseudo-plastic fluid with shear thinning, thixotropy and yield stress. The optimal model of PAE released from PAE/mPEG-PAMAM G5.NHAc and PAE/mPEG-PAMAM G5.NHAc/DGG were the Higuchi equation and the Korsmeyer-Peppas equation, respectively. The cytotoxicity of the nanocomposites showed a concentration-dependence, and the cell viabilities of PAE/mPEG-PAMAM G5.NHAc were both higher than 95% between 0.0001 μM and 10 μM. mPEG-PAMAM G5.NH(2)-FITC was efficiently taken up by cells and exhibited strong fluorescence in the cytoplasm and nucleus. Significant accumulation of nanocomposites was observed in the brain after administration of the in situ gel group, and maximum accumulation was reached at 12 h. A small amount of accumulation was observed in the nanocomposite solution group only at 2 h. Therefore, the direct nasal brain transport efficiency of PAMAM dendrimer nanocomposites can be significantly improved after combining with in situ gel. PAMAM dendrimer nanocomposite/DGG is a potential drug delivery system for nasal brain transport.
format Online
Article
Text
id pubmed-6409925
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-64099252019-03-11 An Available Strategy for Nasal Brain Transport of Nanocomposite Based on PAMAM Dendrimers via In Situ Gel Xie, Huichao Li, Lingjun Sun, Yue Wang, Yuzhen Gao, Shuang Tian, Yuan Ma, Xuemei Guo, Chengcheng Bo, Fumin Zhang, Li Nanomaterials (Basel) Article Polyamidoamine (PAMAM) dendrimers are efficient drug carriers. The presence of a physiological pathway for nasal brain transport provides a potential path for direct brain-targeted delivery of dendrimer nanocomposites. In this study, we synthesized PAMAM dendrimer composites with a nanoscale size; the particle size of PAE (Paeonol)/mPEG (the heterofunctional PEG polymer with a methoxy)-PAMAM G5.NHAc and mPEG-PAMAM G5.NH(2)-FITC were 72.41 ± 11.58 nm and 96.51 ± 7.77 nm, and the zeta potential of PAE/mPEG-PAMAM G5.NHAc and mPEG-PAMAM G5.NH(2)-FITC were + 0.57 ± 0.11 mv and + 9.60 ± 0.41 mv, respectively. The EE% and DL% of PAE in PAE/mPEG-PAMAM G5.NHAc were 53.77% and 13.92%, respectively. PAE/mPEG-PAMAM G5.NHAc/DGG ionic-sensitive in situ gel was prepared, the viscosity of solution and gel state were 112 ± 3.2 mPa and 1403 ± 38.5 mPa, respectively. The in vitro goat mucoadhesive strength of the gel was 4763.36 ± 85.39 dyne/cm(2). In situ gel system was proven to be a non-Newtonian pseudo-plastic fluid with shear thinning, thixotropy and yield stress. The optimal model of PAE released from PAE/mPEG-PAMAM G5.NHAc and PAE/mPEG-PAMAM G5.NHAc/DGG were the Higuchi equation and the Korsmeyer-Peppas equation, respectively. The cytotoxicity of the nanocomposites showed a concentration-dependence, and the cell viabilities of PAE/mPEG-PAMAM G5.NHAc were both higher than 95% between 0.0001 μM and 10 μM. mPEG-PAMAM G5.NH(2)-FITC was efficiently taken up by cells and exhibited strong fluorescence in the cytoplasm and nucleus. Significant accumulation of nanocomposites was observed in the brain after administration of the in situ gel group, and maximum accumulation was reached at 12 h. A small amount of accumulation was observed in the nanocomposite solution group only at 2 h. Therefore, the direct nasal brain transport efficiency of PAMAM dendrimer nanocomposites can be significantly improved after combining with in situ gel. PAMAM dendrimer nanocomposite/DGG is a potential drug delivery system for nasal brain transport. MDPI 2019-01-24 /pmc/articles/PMC6409925/ /pubmed/30682799 http://dx.doi.org/10.3390/nano9020147 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Xie, Huichao
Li, Lingjun
Sun, Yue
Wang, Yuzhen
Gao, Shuang
Tian, Yuan
Ma, Xuemei
Guo, Chengcheng
Bo, Fumin
Zhang, Li
An Available Strategy for Nasal Brain Transport of Nanocomposite Based on PAMAM Dendrimers via In Situ Gel
title An Available Strategy for Nasal Brain Transport of Nanocomposite Based on PAMAM Dendrimers via In Situ Gel
title_full An Available Strategy for Nasal Brain Transport of Nanocomposite Based on PAMAM Dendrimers via In Situ Gel
title_fullStr An Available Strategy for Nasal Brain Transport of Nanocomposite Based on PAMAM Dendrimers via In Situ Gel
title_full_unstemmed An Available Strategy for Nasal Brain Transport of Nanocomposite Based on PAMAM Dendrimers via In Situ Gel
title_short An Available Strategy for Nasal Brain Transport of Nanocomposite Based on PAMAM Dendrimers via In Situ Gel
title_sort available strategy for nasal brain transport of nanocomposite based on pamam dendrimers via in situ gel
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6409925/
https://www.ncbi.nlm.nih.gov/pubmed/30682799
http://dx.doi.org/10.3390/nano9020147
work_keys_str_mv AT xiehuichao anavailablestrategyfornasalbraintransportofnanocompositebasedonpamamdendrimersviainsitugel
AT lilingjun anavailablestrategyfornasalbraintransportofnanocompositebasedonpamamdendrimersviainsitugel
AT sunyue anavailablestrategyfornasalbraintransportofnanocompositebasedonpamamdendrimersviainsitugel
AT wangyuzhen anavailablestrategyfornasalbraintransportofnanocompositebasedonpamamdendrimersviainsitugel
AT gaoshuang anavailablestrategyfornasalbraintransportofnanocompositebasedonpamamdendrimersviainsitugel
AT tianyuan anavailablestrategyfornasalbraintransportofnanocompositebasedonpamamdendrimersviainsitugel
AT maxuemei anavailablestrategyfornasalbraintransportofnanocompositebasedonpamamdendrimersviainsitugel
AT guochengcheng anavailablestrategyfornasalbraintransportofnanocompositebasedonpamamdendrimersviainsitugel
AT bofumin anavailablestrategyfornasalbraintransportofnanocompositebasedonpamamdendrimersviainsitugel
AT zhangli anavailablestrategyfornasalbraintransportofnanocompositebasedonpamamdendrimersviainsitugel
AT xiehuichao availablestrategyfornasalbraintransportofnanocompositebasedonpamamdendrimersviainsitugel
AT lilingjun availablestrategyfornasalbraintransportofnanocompositebasedonpamamdendrimersviainsitugel
AT sunyue availablestrategyfornasalbraintransportofnanocompositebasedonpamamdendrimersviainsitugel
AT wangyuzhen availablestrategyfornasalbraintransportofnanocompositebasedonpamamdendrimersviainsitugel
AT gaoshuang availablestrategyfornasalbraintransportofnanocompositebasedonpamamdendrimersviainsitugel
AT tianyuan availablestrategyfornasalbraintransportofnanocompositebasedonpamamdendrimersviainsitugel
AT maxuemei availablestrategyfornasalbraintransportofnanocompositebasedonpamamdendrimersviainsitugel
AT guochengcheng availablestrategyfornasalbraintransportofnanocompositebasedonpamamdendrimersviainsitugel
AT bofumin availablestrategyfornasalbraintransportofnanocompositebasedonpamamdendrimersviainsitugel
AT zhangli availablestrategyfornasalbraintransportofnanocompositebasedonpamamdendrimersviainsitugel